The building housing BioMed Lublin is seen in Lublin, Poland on August 18, 2020. BioMed Lublin together with the Lublin Medical University announced a trial-ready version of their drug for the treatment of COVID-19 patients on August 18, 2020. The drug has been developed with plasma donated from blood taken from infected miners from the Silesia region of Poland.
Editorial use only Contact your sales representative for commercial and promotional uses.License this clip
More footage filed by NurPhoto videographers.